Release Date: 31/03/17 08:24 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.56MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%